MX2009001635A - Forma de cristal de epotilona b y su uso en composiciones farmaceuticas. - Google Patents

Forma de cristal de epotilona b y su uso en composiciones farmaceuticas.

Info

Publication number
MX2009001635A
MX2009001635A MX2009001635A MX2009001635A MX2009001635A MX 2009001635 A MX2009001635 A MX 2009001635A MX 2009001635 A MX2009001635 A MX 2009001635A MX 2009001635 A MX2009001635 A MX 2009001635A MX 2009001635 A MX2009001635 A MX 2009001635A
Authority
MX
Mexico
Prior art keywords
epothilone
pharmaceutical compositions
crystal form
relates
crystal forms
Prior art date
Application number
MX2009001635A
Other languages
English (en)
Inventor
Ernst Kuesters
Michael Mutz
Frank Stowasser
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37685905&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX2009001635(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MX2009001635A publication Critical patent/MX2009001635A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La invención se refiere a nuevas formas de cristal de la epotilona B.
MX2009001635A 2006-08-16 2007-08-14 Forma de cristal de epotilona b y su uso en composiciones farmaceuticas. MX2009001635A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06119043 2006-08-16
PCT/EP2007/007173 WO2008019820A2 (en) 2006-08-16 2007-08-14 Crystal form of epothilone b and use in pharmaceutical compositions

Publications (1)

Publication Number Publication Date
MX2009001635A true MX2009001635A (es) 2009-02-23

Family

ID=37685905

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009001635A MX2009001635A (es) 2006-08-16 2007-08-14 Forma de cristal de epotilona b y su uso en composiciones farmaceuticas.

Country Status (22)

Country Link
US (1) US8178566B2 (es)
EP (1) EP2064216A2 (es)
JP (1) JP2010500387A (es)
KR (1) KR20090038902A (es)
CN (1) CN101506217B (es)
AR (1) AR062375A1 (es)
AU (1) AU2007286454A1 (es)
BR (1) BRPI0715963A2 (es)
CA (1) CA2658475A1 (es)
CL (1) CL2007002362A1 (es)
IL (1) IL196558A0 (es)
MA (1) MA30656B1 (es)
MX (1) MX2009001635A (es)
MY (1) MY148355A (es)
NO (1) NO20091081L (es)
NZ (1) NZ574194A (es)
PE (1) PE20081317A1 (es)
RU (1) RU2009109352A (es)
TN (1) TN2009000044A1 (es)
TW (1) TW200815455A (es)
WO (1) WO2008019820A2 (es)
ZA (1) ZA200900227B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011146638A1 (en) 2010-05-18 2011-11-24 Cerulean Pharma Inc. Compositions and methods for treatment of autoimmune and other diseases
CN103910742B (zh) * 2013-01-07 2016-07-13 浙江海正药业股份有限公司 一种制备埃博霉素b无定形粉末的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1623543A (zh) 1998-02-05 2005-06-08 诺瓦提斯公司 依普西龙组合物
US6194181B1 (en) * 1998-02-19 2001-02-27 Novartis Ag Fermentative preparation process for and crystal forms of cytostatics
UA75365C2 (en) 2000-08-16 2006-04-17 Bristol Myers Squibb Co Epothilone analog polymorph modifications, a method for obtaining thereof (variants), a pharmaceutical composition based thereon
GB0029895D0 (en) 2000-12-07 2001-01-24 Novartis Ag Organic compounds
CN101050445B (zh) * 2002-09-23 2011-08-10 布里斯托尔-迈尔斯斯奎布公司 产埃坡霉素的微生物

Also Published As

Publication number Publication date
WO2008019820A3 (en) 2008-04-17
CL2007002362A1 (es) 2008-08-08
NZ574194A (en) 2011-12-22
CA2658475A1 (en) 2008-02-21
MY148355A (en) 2013-03-29
AU2007286454A1 (en) 2008-02-21
TW200815455A (en) 2008-04-01
PE20081317A1 (es) 2008-10-28
IL196558A0 (en) 2009-11-18
RU2009109352A (ru) 2010-09-27
NO20091081L (no) 2009-03-16
ZA200900227B (en) 2009-12-30
TN2009000044A1 (en) 2010-08-19
CN101506217B (zh) 2012-09-05
AR062375A1 (es) 2008-11-05
US20100160393A1 (en) 2010-06-24
KR20090038902A (ko) 2009-04-21
BRPI0715963A2 (pt) 2013-08-06
CN101506217A (zh) 2009-08-12
WO2008019820A2 (en) 2008-02-21
US8178566B2 (en) 2012-05-15
EP2064216A2 (en) 2009-06-03
JP2010500387A (ja) 2010-01-07
MA30656B1 (fr) 2009-08-03

Similar Documents

Publication Publication Date Title
EP2152304A4 (en) THERAPEUTIC COMPOSITIONS IN NANOEMULSION FORM AND METHOD OF APPLICATION THEREFOR
TW200637490A (en) Fertilizer-compatible composition
IL197161A0 (en) Derivatives of 4-(n-azacycloalkyl)anilides and compositions containing the same
GB0515353D0 (en) Food
IL195161A0 (en) Pharmaceutical compositions of ropinirole and methods of use thereof
TN2010000060A1 (en) Proteasome inhibitors
TW200728285A (en) Diacylindazole derivatives as inhibitors of lipases and phospholipases
WO2007115821A3 (en) Organic compounds
EP2104513A4 (en) OVR110 ANTIBODY COMPOSITIONS AND METHODS OF USE
TN2010000203A1 (en) Beta-lactamase inhibitors
EP2056835A4 (en) PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
UA91848C2 (ru) Применение соединений диосметина в лечении и предотвращении тромботическим патологиям
SI2368555T1 (sl) Sestavki in metode za uporabo forbol estrov
HK1142608A1 (en) 5-pyridinone substituted indazoles and pharmaceutical compositions thereof 5-
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
SG158091A1 (en) Imidazoazepinone compounds
EP1933805A4 (en) INFLAMMATORY COMPOSITIONS AND METHODS OF ADMINISTRATION
MX341064B (es) Variantes de la familia il-1.
EP2361907A4 (en) THE FIVE CRYSTALLINE FORMS OF NICOUSAMIDE, PREPARATION METHODS, PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
GB0614365D0 (en) Pharmaceutical compositions and their use
EP2029132A4 (en) ANTIHISTAMINE COMPOSITIONS AND THEIR USE
MY146803A (en) Benzothiazol-2-on derivatives as lipase and phospholipase inhibitors
CA117276S (en) Spatula
MX2009013126A (es) Nuevos compuestos 892.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal